Scientia Ventures — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
1910 develops an AI platform that integrates multimodal data, frontier AI models, and high-throughput lab automation to accelerate drug discovery and development for pharmaceutical companies.
AI & Machine LearningBiotechDeep TechHealthtechBoston, US
Jen Asher(CEO)inJennifer O. Nwankwo(Executive Officer, Director)Jen Nwankwo(Founder)
BoardSamir Kumar(Director)Marc Foster(Director)Jory Bell(Director)in
Co-investorsFoundersX VenturesPlayground GlobalY CombinatorEmles Venture PartnersJude GomilaM12 (Microsoft's Venture Fund)+5 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






